Financial Architects, Inc Dexcom Inc Call Options Transaction History

Financial Architects, Inc

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2019 Aug 14, 2019	BUY	$27.84 - $38.92 $30,624 - $42,812	1,100 Added 1100.0%	1,200 $180,000
Q1 2019 May 13, 2019	BUY	$28.07 - $38.18 $2,807 - $3,818	100 New	100 $12,000
Q1 2019 May 03, 2019	SELL	$28.07 - $38.18 $101,052 - $137,448	-3,600 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$26.99 - $37.37 $97,164 - $134,532	3,600 New	3,600 $432,000

1,016

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.